Whitepaper
Investment Insights
The Pharma and Healthcare segments are undergoing constant changes. Post pandemic, there has been an increase in traction for investment in the pharmaceutical industry. Investors are slowly gaining the confidence that was shaken due to the pandemic.
Compared to the investments in 2019, there has been a steady rise in healthcare investments, especially in biopharma and health technology, closely followed by diagnostics. The healthcare investment trend is expected to continue in 2022 as travel has begun and sectors are moving back to normalcy.
The M&A deals, on the other hand, remained unaffected during the pandemic and there were substantial deals that were signed during the peak pandemic phase.
To know more...
Authors
White Papers
China Real Estate - In Desperate Need of More Policy...
China’s real estate sector has been significantly impacted by the introduction of the three red lines policy, eventually leading to a liquidity crunch...
